Exogenous Ketones for Acutely Decompensated HEart Failure

计划入组 24 人 · 首次发布于 2021 年 1 月 6 日

American Registry of Ambulatory or Acutely Decompensated Heart Failure

计划入组 6,732 人 · 首次发布于 2022 年 3 月 25 日

Validation of a Mortality Prediction Model for Acutely Decompensated Heart Failure Patients

计划入组 226 人 · 首次发布于 2007 年 9 月 27 日

Levosimendan

<dd class="col-xl-8 col-md-9 col-sm-8">C₁₄H₁₂N₆O</dd> · Rx

Nesiritide

Rx

heart regeneration therapy (congestive heart failure)

BERLIN HEART, INC.

United States

KEYSTONE HEART LTD

Israel

Heart Metabolics Ltd.

Ireland

Tenax Therapeutics Secures European Patent Protection for Levosimendan in PH-HFpEF Through 2040

WhiteSwell's eLym System Shows Promise in Acute Heart Failure Fluid Management Trial

Catheter Precision Acquires Cardionomic's Heart Failure Technology for Novel Neuromodulation Therapy